Literature DB >> 21859829

Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin.

Jeremy H Tchaicha1, Steve B Reyes, Jaekyung Shin, Mohammad G Hossain, Frederick F Lang, Joseph H McCarty.   

Abstract

Glioblastoma multiforme (GBM) is a highly invasive brain tumor that develops florid microvascular proliferation and hemorrhage. However, mechanisms that favor invasion versus angiogenesis in this setting remain largely uncharacterized. Here, we show that integrin β8 is an essential regulator of both GBM-induced angiogenesis and tumor cell invasiveness. Highly angiogenic and poorly invasive tumors expressed low levels of β8 integrin, whereas highly invasive tumors with limited neovascularization expressed high levels of β8 integrin. Manipulating β8 integrin protein levels altered the angiogenic and invasive growth properties of GBMs, in part, reflected by a diminished activation of latent TGFβs, which are extracellular matrix protein ligands for β8 integrin. Taken together, these results establish a role for β8 integrin in differential control of angiogenesis versus tumor cell invasion in GBM. Our findings suggest that inhibiting β8 integrin or TGFβ signaling may diminish tumor cell invasiveness during malignant progression and following antivascular therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859829      PMCID: PMC3193578          DOI: 10.1158/0008-5472.CAN-11-0991

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.

Authors:  L Fang; Z Deng; T Shatseva; J Yang; C Peng; W W Du; A J Yee; L C Ang; C He; S W Shan; B B Yang
Journal:  Oncogene       Date:  2010-10-18       Impact factor: 9.867

2.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.

Authors:  Y Sonoda; T Ozawa; Y Hirose; K D Aldape; M McMahon; M S Berger; R O Pieper
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  Central nervous system cancers.

Authors:  Steven S Brem; Philip J Bierman; Henry Brem; Nicholas Butowski; Marc C Chamberlain; Ennio A Chiocca; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Deneen Hesser; Larry Junck; Gerald P Linette; Jay S Loeffler; Moshe H Maor; Madison Michael; Paul L Moots; Tara Morrison; Maciej Mrugala; Louis Burt Nabors; Herbert B Newton; Jana Portnow; Jeffrey J Raizer; Lawrence Recht; Dennis C Shrieve; Allen K Sills; Frank D Vrionis; Patrick Y Wen
Journal:  J Natl Compr Canc Netw       Date:  2011-04       Impact factor: 11.908

4.  A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth.

Authors:  S Cambier; D Z Mu; D O'Connell; K Boylen; W Travis; W H Liu; V C Broaddus; S L Nishimura
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

5.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.

Authors:  T Sánchez-Elsner; L M Botella; B Velasco; A Corbí; L Attisano; C Bernabéu
Journal:  J Biol Chem       Date:  2001-08-02       Impact factor: 5.157

7.  Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.

Authors:  S Chatterjee; A Matsumura; J Schradermeier; G Y Gillespie
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

8.  Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.

Authors:  A Erdreich-Epstein; H Shimada; S Groshen; M Liu; L S Metelitsa; K S Kim; M F Stins; R C Seeger; D L Durden
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

9.  Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

Authors:  L Bello; M Francolini; P Marthyn; J Zhang; R S Carroll; D C Nikas; J F Strasser; R Villani; D A Cheresh; P M Black
Journal:  Neurosurgery       Date:  2001-08       Impact factor: 4.654

10.  The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1.

Authors:  Dezhi Mu; Stephanie Cambier; Lars Fjellbirkeland; Jody L Baron; John S Munger; Hisaaki Kawakatsu; Dean Sheppard; V Courtney Broaddus; Stephen L Nishimura
Journal:  J Cell Biol       Date:  2002-04-22       Impact factor: 10.539

View more
  49 in total

1.  Protein tyrosine phosphatase-PEST and β8 integrin regulate spatiotemporal patterns of RhoGDI1 activation in migrating cells.

Authors:  Hye Shin Lee; Mujeeburahiman Cheerathodi; Sankar P Chaki; Steve B Reyes; Yanhua Zheng; Zhimin Lu; Helena Paidassi; Celine DerMardirossian; Adam Lacy-Hulbert; Gonzalo M Rivera; Joseph H McCarty
Journal:  Mol Cell Biol       Date:  2015-02-09       Impact factor: 4.272

2.  Selective expression of eGFP in mouse perivascular astrocytes by modification of the Mlc1 gene using T2A-based ribosome skipping.

Authors:  Jordan J Toutounchian; Joseph H McCarty
Journal:  Genesis       Date:  2017-10-06       Impact factor: 2.487

3.  Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.

Authors:  P A Guerrero; J H Tchaicha; Z Chen; J E Morales; N McCarty; Q Wang; E P Sulman; G Fuller; F F Lang; G Rao; J H McCarty
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

Review 4.  αvβ8 integrin adhesion and signaling pathways in development, physiology and disease.

Authors:  Joseph H McCarty
Journal:  J Cell Sci       Date:  2020-06-15       Impact factor: 5.285

Review 5.  Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.

Authors:  Sean Mahase; Rachel N Rattenni; Pieter Wesseling; William Leenders; Clarissa Baldotto; Rajan Jain; David Zagzag
Journal:  Am J Pathol       Date:  2017-03-09       Impact factor: 4.307

6.  Comprehensive bioinformation analysis of the miRNA of PLCE1 knockdown in esophageal squamous cell carcinoma.

Authors:  Xiaobin Cui; Kaige Wang; Xinqian Yang; Hao Peng; Xi Chen; Huahua Xin; Yanxia Tian; Yunzhao Chen; Feng Li
Journal:  Mol Cell Biochem       Date:  2017-12-13       Impact factor: 3.396

Review 7.  Adaptation to antiangiogenic therapy in neurological tumors.

Authors:  Patrick M Flanigan; Manish K Aghi
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

8.  PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.

Authors:  Zhihua Chen; John E Morales; Paola A Guerrero; Huandong Sun; Joseph H McCarty
Journal:  Cancer Res       Date:  2018-05-09       Impact factor: 12.701

9.  Transcriptomics of cortical gray matter thickness decline during normal aging.

Authors:  P Kochunov; J Charlesworth; A Winkler; L E Hong; T E Nichols; J E Curran; E Sprooten; N Jahanshad; P M Thompson; M P Johnson; J W Kent; B A Landman; B Mitchell; S A Cole; T D Dyer; E K Moses; H H H Goring; L Almasy; R Duggirala; R L Olvera; D C Glahn; J Blangero
Journal:  Neuroimage       Date:  2013-05-24       Impact factor: 6.556

10.  The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma.

Authors:  Mujeeburahiman Cheerathodi; Naze G Avci; Paola A Guerrero; Leung K Tang; Julia Popp; John E Morales; Zhihua Chen; Amancio Carnero; Frederick F Lang; Bryan A Ballif; Gonzalo M Rivera; Joseph H McCarty
Journal:  Mol Cancer Res       Date:  2016-09-21       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.